Policy

The CVP recognizes policy as a critically important vehicle to address the burden of chronic disease for vulnerable populations. Below are some examples of ways in which the CVP has advanced the public policy agenda for vulnerable populations faced with chronic disease, and in support of the practitioners and systems that disproportionately serve these populations.

Adapting the Coronary Heart Disease Policy Model to Address Disparities in Heart Disease
CVP director, Dr. Kirsten Bibbins-Domingo has adapted the Coronary Heart Disease Policy Model (CHDPM) to address disparities in heart disease. The CHDPM is a dynamic computer simulation of disease. This is a useful tool for projecting the population impact of clinical trial results, for comparing the effectiveness of prevention and treatment guidelines, for synthesizing multiple lines of scientific evidence, and for projecting disease trends. The studies conducted with the CHDPM have great potential to drive public policy because national, state and local health policy is often evaluated for the ability to eliminate health disparities between different sub-populations. The adaption of the Coronary Heart Disease Policy Model to examine coronary heart disease rates by race/ethnicity and income level enables a more accurate description of disease trends over diverse populations and evaluation of interventions that target vulnerable groups. Dr. Bibbins-Domingo has presented preliminary results and made policy recommendations regarding salt policy to the California Department of Public Health. Additionally, among other ongoing and concluded studies, she is studying the impact of taxation of sugar-sweetened beverages on cardiovascular health in California and the United States.